Title: Management of Post Operative Mastalgia after Excision of Fibroadenoma with Use of A Vitamin E

Authors: Jain Neeraj Kumar, Maini Sunil, Khobragade Vicky, Jain Manjari

 DOI:  https://dx.doi.org/10.18535/jmscr/v4i12.46

Abstract

Background: Mastalgia is defined as a dull ache or heaviness in the breast. Post operative mastalgia is a common condition occurring in about 30% of women after operation. Mastalgia after Excision of fibroadenoma poses a significant problem to the surgeons. Post operative mastalgia can significantly affect the quality of life in some women. The major question that worries the patient is inadequate excision of swelling or the risk of malignancy. Reassurance plays a key role. This study was done to assess the efficiency of vitamin E in treating post operative mastalgia in young women.

Method- Our prospective observational study was conducted at Department of General Surgery, R.K.D.F. Medical College & Research Centre, Bhopal, during period of November 2013 to November 2015. Total 320 cases of Breast Lump came in Hospital for treatment. FNAC and Core Biopsy was done in all cases. Patient with fibroadenoma were operated and included in the study. Patients were  called for follow up on 15th day of surgery and patient with  post operative  breast pain  were given  Vitamin E (200mg od for 3 month) and their pain grading was done with Numerical pain grading scale .After 3 months  follow up cases were assessed for mastalgia  on Numerical pain grading scale.

Result- In this study of 320 patients of Breast Lump, fibroadenoma was present in 221 (69.06%) patients and mastalgia after surgery was present in 94 (42.53%) patients. Out of 94 patients with Post operative mastalgia 74 (78.7%) recovered. In present study, significant (p value<0.001) association was found between postoperative mastalgia and use of vitamin E

So it can be concluded that Vitamin E can be used to manage post surgery mastaliga in cases of fibroadenoma.

Conclusion-: Oxidative stress may be the cause for mastalgia after surgery. Vitamin E at a dosage of 200 mg once daily for 3months has a significant role in the management of such cases.

Keywords-Mastalgia, fibroadenoma, Vitamin E , Breast Lump, Breast pain.

References

1.      Arca MJ, Caniano DA. Breast disorders in the adolescent patient. Adolesc Med Clin, 2004; 15(3): 473-485.

2.      Norman s Williams, Christopher JK, Bulstrode , P ronanan O Connell. Bailey & Love’s, Short Practice of surgery 26e (CRC Press book 2008) 8-16.

3.      Courtney M. Townsend,R. Daniel Beauhamp, B. Mark Evers, Kenneth L.Mattox.Sabiston Text book of surgery18e( Elsevier Inc. 2009) 866-   868.

4.      Dupont WD, Page DL, Parl FF, Vnencak-Jones CL, Plummer WD, Jr, Rados MS, et al. Long-term risk of breast cancer in women with      fibroadenoma.   N Engl J Med, 1994; 331(1): 10-15.

5.      West KW, Rescorla FJ, Scherer LR, III, Grosfeld JL. Diagnosis and treatment of symptomatic breast masses in the pediatric population. J Pediatr Surg, 1995; 30(2): 182- 186.

6.      Kyriakos Kalogerakos, Chrisostomos Sofoudis, Nikolaos Baltayiannis. Early breast cancer, A  review. Cancer Therapy, 2008; 6: 463-476.

7.      Van der Heiden E, Bechoux N, Muller M, et al. Food flavonoid aryl hydrocarbon receptor-mediated agonistic/antagonistic/synergic activities in human and rat reporter gene assays. Anal Chim Acta, 2009; 637: 337–45.

8.      Dijkstra SC, Lampe JW, Ray RM, et al. Biomarkers of dietary exposure are associated with lower risk of breast fibroadenomas in Chinese women. J Nutr,   2010; 140: 1302-10.

9.      Bundred NJ. Etiological factors in benign breast disease. Br J Surg, 1994; 81: 788–9.

10.  Pasqualini JR, Cortes-Prieto J, Chetrite G, et al. Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma. Int J Cancer, 1997; 70: 639–43.

11.  Coriaty Nelson Z, Ray RM, Gao DL, et al. Risk factors for fibroadenoma in a cohort of female textile workers in Shanghai, China. Am J Epidemiol, 2002; 156: 599-605.

12.  Einbond L.S., Wen-Cai Y., He K., Wu H.A., Cruz E., Roller M. and Kronenberg F. Growth inhibitory activity of extracts and compounds from Cimicifuga species on human breast cancer cells, Phytomedicine, 2008; 15(6): 504-511.

13.  Pashby NL, Mansel RE, Hughes LE. A clinical trial of evening primrose oil in mastalgia. Br J Surg. 1981;68:801. doi: 10.1002/bjs.1800681115. 

14.  Srivastava A, Mansel RE, Arvinda N. Evidence-based management of mastalgia: a meta-analysis of randomized trials. Breast. 2007;16(5):503–512. doi: 10.1016/j.breast.2007.03.003.

15.  Greenblatt RB, Dmowske WP, Mhesh VB. Clinical studies with an antigonadot-rophin—danazol. Fertil Steril. 1971;22: 102–112. 

16.  Shukla HS, Kumar S. Benign breast disorders in nonwestern populations: Part II—benign breast disorders in India. World J Surg. 1989;13(6):746–749. doi: 10.1007/BF01658426.

17.  Asch RH, Greenblatt RB. The use of an impeded androgen danazol in the manag-ement of benign breast disorders.  Am J Obstet Gynecol.  1971;127:130–134. 

18.  Gonenc A, Tokgoz D, Aslan S, Torun M. oxidative stresses in relation to lipid profiles in different stages of breast cancer. Indian Journal of Biochemistry and Biophysics, 42:190-194,(2005).

Corresponding Author

Dr Neeraj Kumar Jain

Assistant Professor, Department of General Surgery, RKDF Medical College And Research Centre,

E-7/435, M.I.G., Arera Colony, Bhopal, Madhya Pradesh, India Pin 462016

Phone (or Mobile) No.: +91-(782) 801-2235, +91-(942) 500-4592

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.,This email address is being protected from spambots. You need JavaScript enabled to view it.